Evaluation of the MTHFR A1298C variant in leukoaraiosis

Zoltan Szolnoki1, Istvan Szaniszlo, Marta Szekeres

  • 1Department of Neurology and Cerebrovascular Diseases, Pándy Kálmán County Hospital, Gyula, Hungary. szolnoki99@hotmail.com

Insights

The methylenetetrahydrofolate reductase (MTHFR) A1298C genetic variant is an independent risk factor for leukoaraiosis (LA), a brain condition linked to cognitive decline. This risk is amplified when combined with the MTHFR C677T variant.

Area of Science:

  • Neurology
  • Genetics
  • Vascular Biology

Background:

  • Leukoaraiosis (LA) is common brain white matter demyelination associated with cognitive decline.
  • Elevated serum homocysteine levels are linked to LA, alongside hypertension and aging.
  • The MTHFR C677T variant affects homocysteine but its independent role in LA is unproven.

Purpose of the Study:

  • To investigate the association between the MTHFR A1298C genetic variant and the presence of leukoaraiosis (LA).
  • To determine if MTHFR A1298C is an independent risk factor for LA.
  • To assess the combined effect of MTHFR A1298C and MTHFR C677T variants on LA risk.

Main Methods:

  • Analysis of clinical and genetic data from 198 LA patients and 235 healthy controls.
  • Genotyping for MTHFR A1298C and MTHFR C677T variants.
  • Statistical comparison of variant frequencies between LA patients and controls.

Main Results:

  • The MTHFR A1298C variant (A1298C or 1298CC genotypes) was a significant risk factor for LA compared to the absence of these variants.
  • Co-occurrence of heterozygous MTHFR A1298C and C677T variants increased the risk of LA.
  • The MTHFR A1298C variant demonstrated an independent genetic risk for LA.

Conclusions:

  • The MTHFR A1298C genetic variant is an independent risk factor for leukoaraiosis.
  • The pathological role of MTHFR A1298C in LA may be potentiated by the presence of the MTHFR C677T variant.
  • These findings highlight the genetic contribution of MTHFR variants to leukoaraiosis and cognitive decline.